BioCentury
ARTICLE | Product Development

Mapping opportunities for China’s early cancer detection boom 

How Chinese companies developing liquid biopsies for cancer are approaching the potentially massive market

October 8, 2020 6:46 PM UTC

As investor enthusiasm for blood-based cancer screening soars in the wake of Grail’s $8 billion acquisition,  much of the activity is taking place in China, where a short list of dominant ...



Access this Article